Nectar Lifesciences

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nectar Lifesciences Limited
Type Public
Traded as BSE532649
NSENECLIFE
Industry Pharmaceuticals
Founded 1995
Headquarters Chandigarh, India
Key people Sanjiv Goyal Chairman, Aryan Goyal Executive Director, Dinesh DuaCEO
Products Cephalosporins,
Revenue Increase INR 16.4 billion
Net income Increase INR 1.05 billion
Employees 2200
Website www.neclife.com
Nectar Lifesciences Finished Dosage facility

Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic products for EU and USA.[1] The company is the largest GMP manufacturer of oral and sterile cephalosporins in the world. Its facilities are approved by USFDA, the European Union and Japan.

History[edit]

The company is promoted by Goyal family and was incorporated in June 1995. The company went public in July 2005 with simultaneous listings on Bombay Stock Exchange and the National Stock Exchange of India. In 2010 New Silk Route Private Equity invested INR 2.5 billion in the company.

Management[edit]

The company's chairman and Managing Director is Mr Sanjiv Goyal. Executive Directors: Mr Aryan Goyal, Mr Saurabh Goyal[2]

Market Cap[edit]

The current market capitalization is about INR 9 billion (US$ 180 million).[citation needed]

Products[edit]

Nectar Lifesciences manufactures oral and sterile active pharmaceutical ingredients, finished dosages and phytochemicals. Nectar is the world's largest manufacturer and exporter of natural menthol and allied products. The company is also in business of providing leading pharmaceutical organizations with contract research and manufacturing services. It also manufactures empty hard gelatin capsules.

References[edit]

External links[edit]